Development of antisense oligonucleotide (ASO) technology against Tgf‐β signaling to prevent scarring during flexor tendon repair

Publisher: John Wiley & Sons Inc

E-ISSN: 1554-527x|33|6|859-866

ISSN: 0736-0266

Source: JOURNAL OF ORTHOPAEDIC RESEARCH, Vol.33, Iss.6, 2015-06, pp. : 859-866

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract